<DOC>
	<DOCNO>NCT00004390</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine whether opioid ( morphine ) treatment result well management pain treatment tricyclic antidepressant ( nortriptyline ) . II . Assess effect two treatment affective cognitive function . III . Determine whether presence psychiatric comorbidity , particularly depression , predict outcome two treatment .</brief_summary>
	<brief_title>Phase III Randomized Controlled Study Morphine Nortriptyline Management Postherpetic Neuralgia</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , crossover study . Patients stratified duration pain ( great 1 year great 1 year ) presence absence major depression . Patients randomize 6 treatment order group . Patients start nortriptyline , morphine , placebo , take orally every day . If patient unable tolerate nortriptyline morphine , receive desipramine methadone instead . A drug titration period last 3 week ensue administration first drug treatment . The goal titration period gradually increase dose drug obtain maximal analgesic efficacy . Drug dosage maintain period 3 week . The drug dosage taper followed drug free period 1 week .</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<mesh_term>Desipramine</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnostically confirm postherpetic neuralgia least 3 month follow segmental herpes zoster eruption Prior/Concurrent Therapy Other : No concurrent monoamine oxidase inhibitor Patient Characteristics Life expectancy : At least 6 month Cardiovascular : No second degree complete heart blockage No myocardial infarction last 3 month Pulmonary : No severe pulmonary disease Other : No history substance abuse No history dementia No history encephalopathy No severe depression precludes withdrawal antidepressant Not pregnant No angleclosure glaucoma No AIDS relate disease complex No terminal disease life expectancy le 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2000</verification_date>
	<keyword>disease-related problem/condition</keyword>
	<keyword>herpes zoster infection</keyword>
	<keyword>herpesvirus infection</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>pain</keyword>
	<keyword>rare disease</keyword>
	<keyword>viral infection</keyword>
</DOC>